Bushido Capital US SMID Cap Equity ETF Rating $33.10 +0.03 (+0.09%) As of 07/2/2026 02:50 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsShort InterestTrendsBuy This Stock Bushido Capital US SMID Cap Equity ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.RNIN Aggregate RatingHold 2.37Holdings in RNIN have an aggregate rating of Hold based on 382 analyst ratings issued in the past year covering 25 companies (33.4% of the portfolio).RNIN Aggregate Price Target$33.10High Prediction$33.10Average Prediction$33.10Low Prediction$33.10Holdings in RNIN have an aggregate price target of $33.10 and a range of $33.10 to $33.10 covering 25 companies (33.4% of the portfolio).RNIN Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold12 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Bushido Capital US SMID Cap Equity ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 RNIN Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.42%SYMSymbotic$42.743.457 of 5 stars2.19$65.23 52.6%16News CoverageGap Up1.41%NUTXNutex Health$196.533.6154 of 5 stars2.60$243.33 23.8%5News CoverageGap DownHigh Trading Volume1.38%CARGCarGurus$36.243.0616 of 5 stars2.60$37.77 4.2%15News CoverageInsider TradeGap Down1.38%HALOHalozyme Therapeutics$79.454.222 of 5 stars2.54$81.60 2.7%13News CoverageInsider TradeGap Down1.36%BILLBILL$40.39-0.2%4.5283 of 5 stars2.54$55.19 36.6%24Analyst Upgrade1.36%GDDYGoDaddy$88.42-0.1%4.9835 of 5 stars2.53$118.43 33.9%151.36%PARRPar Pacific$58.56+0.1%3.9258 of 5 stars2.75$70.00 19.5%12News Coverage1.36%RNGRingCentral$40.07+0.2%3.5654 of 5 stars2.25$43.00 7.3%12News CoverageInsider Trade1.35%TRIPTripAdvisor$14.291.8561 of 5 stars2.00$15.19 6.3%16News CoverageGap Down1.34%FRSHFreshworks$10.344.0861 of 5 stars2.47$12.18 17.8%15News Coverage1.33%GTMZoomInfo Technologies$2.994.6358 of 5 stars1.67$6.09 103.8%181.33%NXSTNexstar Media Group$181.094.8622 of 5 stars3.00$259.67 43.4%8Positive News1.33%BLKBBlackbaud$30.093.721 of 5 stars2.00$52.50 74.5%41.33%CHWYChewy$20.78-0.3%4.8052 of 5 stars2.76$32.05 54.2%25Gap Up1.33%MTCHMatch Group$37.904.5828 of 5 stars2.40$41.07 8.4%15News CoverageGap Down1.32%PINSPinterest$22.06-0.1%4.4355 of 5 stars2.43$27.40 24.2%35Analyst ForecastInsider Trade1.32%YELPYelp$26.48-0.2%2.7345 of 5 stars1.75$27.88 5.3%81.32%PTONPeloton Interactive$5.754.6749 of 5 stars2.29$8.25 43.5%14Positive NewsGap Up1.30%LYFTLyft$15.374.8141 of 5 stars2.27$19.40 26.2%37Positive NewsGap Down1.30%ANFAbercrombie & Fitch$92.410.0%4.0289 of 5 stars2.54$112.64 21.9%131.30%HRBH&R Block$40.01-0.1%3.6755 of 5 stars2.50$41.00 2.5%4Analyst Upgrade1.30%YOUCLEAR Secure$53.81+0.0%4.456 of 5 stars2.67$60.00 11.5%9Positive NewsGap Up1.29%PATHUiPath$11.68-0.3%4.0281 of 5 stars2.06$13.80 18.2%17Gap Down1.29%HRMYHarmony Biosciences$37.264.556 of 5 stars2.27$41.44 11.2%11Analyst ForecastGap Down1.28%INSPInspire Medical Systems$46.95+0.0%4.6146 of 5 stars2.14$81.05 72.6%21Positive NewsAnalyst Upgrade This page (NASDAQ:RNIN) was last updated on 7/5/2026 by MarketBeat.com Staff. From Our PartnersTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bushido Capital US SMID Cap Equity ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Bushido Capital US SMID Cap Equity ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
